REGENERON PHARMACEUTICALS, INC. (REGN) Operating income 2016–2025
REGENERON PHARMACEUTICALS, INC. (REGN) annual operating income history from SEC filings — each fiscal year as reported.
$3.6BFY2025 · since FY2016: $1.3B → $3.6B
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $3.6B | -10.3% |
| FY2024 | $4.0B | -1.4% |
| FY2023 | $4.0B | -14.6% |
| FY2022 | $4.7B | -47.0% |
| FY2021 | $8.9B | +150.1% |
| FY2020 | $3.6B | +61.9% |
| FY2019 | $2.2B | -12.8% |
| FY2018 | $2.5B | +21.9% |
| FY2017 | $2.1B | +56.3% |
| FY2016 | $1.3B | — |
Source: SEC XBRL filings · For reference only · Not investment advice